Rigel Pharmaceuticals

RIGL NASDAQ Santé & Biotech États-Unis US7665596034
30.91 $
0.62 %

Rigel Pharmaceuticals est engagée dans la recherche et le développement de médicaments innovants pour le traitement de maladies auto-immunes et inflammatoires.

Performance & Momentum

6 Months 30.78 %
1 Year 37.48 %
3 Years 85.43 %
5 Years 25.27 %

Similar stocks to Rigel Pharmaceuticals

Anantys Community

Be the first to share your analysis on Rigel Pharmaceuticals.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases